Get startedLog in
    Picture of Hangzhou Jiuyuan Genetic Biopharmaceutical logo

    2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapContrarian
    All News

    Brief: Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY47 Injection IND Application Obtains Clinical Trial Approval From NMPA

    Picture of Hangzhou Jiuyuan Genetic Biopharmaceutical logoHangzhou Jiuyuan Genetic Biopharmaceutical
    17/03/2026 10:34
    March 17 (Reuters) - Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd 2566.HK:

JY47 INJECTION IND APPLICATION OBTAINS CLINICAL TRIAL APPROVAL FROM NMPA

Further company coverage: 2566.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Hangzhou Jiuyuan Genetic Biopharmaceutical

    See all news